247 related articles for article (PubMed ID: 25675888)
1. The new Occlutech® PDA occluder: Initial human experience.
Abdelbasit MA; Alwi M; Kandavello G; Che Mood M; Samion H; Hijazi ZM
Catheter Cardiovasc Interv; 2015 Jul; 86(1):94-9. PubMed ID: 25675888
[TBL] [Abstract][Full Text] [Related]
2. Transcatheter Closure of Patent Ductus Arteriosus in Children with the Occlutech Duct Occluder.
Bilici M; Demir F; Akın A; Türe M; Balık H; Kuyumcu M
Pediatr Cardiol; 2017 Dec; 38(8):1598-1605. PubMed ID: 28828684
[TBL] [Abstract][Full Text] [Related]
3. The new Occlutech(®) patent ductus arteriosus occluder: Single centre experience.
Boudjemline Y
Arch Cardiovasc Dis; 2016; 109(6-7):384-9. PubMed ID: 26988839
[TBL] [Abstract][Full Text] [Related]
4. Closure of very large PDA with pulmonary hypertension: Initial clinical case-series with the new Occlutech
Lehner A; Ulrich S; Happel CM; Fischer M; Kantzis M; Schulze-Neick I; Haas NA
Catheter Cardiovasc Interv; 2017 Mar; 89(4):718-725. PubMed ID: 27860161
[TBL] [Abstract][Full Text] [Related]
5. Prospective evaluation of the feasibility, safety, and efficacy of Cocoon Duct Occluder for transcatheter closure of large patent ductus arteriosus: A single-center study with short- and medium-term follow-up results.
Sinha SK; Razi M; Pandey RN; Kumar P; Krishna V; Jha MJ; Mishra V; Asif M; Abdali N; Tewari P; Thakur R; Pandey U; Varma CM
Anatol J Cardiol; 2017 Nov; 18(5):321-327. PubMed ID: 29145233
[TBL] [Abstract][Full Text] [Related]
6. Is the new Occlutech duct occluder an appropriate device for transcatheter closure of patent ductus arteriosus?
Godart F; Houeijeh A; Domanski O; Guillaume MP; Brard M; Lucron H
Int J Cardiol; 2018 Jun; 261():54-57. PubMed ID: 29551254
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous closure of the patent ductus arteriosus using the Nit-Occlud PDA-R (reverse) device: initial experience reporting immediate and short-term results.
Peirone A; Diaz J; Contreras A; Banille E; Cabrera M; Spillmann A; Bueno N; Juaneda E
J Invasive Cardiol; 2011 Dec; 23(12):513-6. PubMed ID: 22147399
[TBL] [Abstract][Full Text] [Related]
8. Short-Term Outcomes of Patent Ductus Arteriosus Closure With New Occlutech® Duct Occluder: A Multicenter Study.
Dedeoglu R; Bilici M; Demir F; Demir F; Acar OÇ; Hallioglu O; Pac A; Kiziltas A; Karabel D; Kula S; Cimen D; Baspinar O; Atik SU; Saltik IL
J Interv Cardiol; 2016 Jun; 29(3):325-31. PubMed ID: 27090770
[TBL] [Abstract][Full Text] [Related]
9. The Amplatzer Duct Occluder II Additional Sizes device for transcatheter PDA closure: initial experience.
Bruckheimer E; Godfrey M; Dagan T; Levinzon M; Amir G; Birk E
Catheter Cardiovasc Interv; 2014 Jun; 83(7):1097-101. PubMed ID: 24532416
[TBL] [Abstract][Full Text] [Related]
10. Transcatheter closure of calcified patent ductus arteriosus in older adult patients: Immediate and 12-month follow-up results.
Gu X; Zhang Q; Sun H; Fei J; Zhang X; Kutryk MJ
Congenit Heart Dis; 2017 May; 12(3):289-293. PubMed ID: 27874259
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous closure of a moderate to large tubular or elongated patent ductus arteriosus in children younger than 3 years: is the ADO II appropriate?
Kumar SM; Subramanian V; Bijulal S; Krishnamoorthy KM; Sivasankaran S; Tharakan JA
Pediatr Cardiol; 2013 Oct; 34(7):1661-7. PubMed ID: 23591801
[TBL] [Abstract][Full Text] [Related]
12. Contemporary outcomes of percutaneous closure of patent ductus arteriosus in adolescents and adults.
P S; Jose J; George OK
Indian Heart J; 2018; 70(2):308-315. PubMed ID: 29716712
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of transcatheter closure of patent ductus arteriosus with the off-label use of large occluders (≥16 mm).
Kanabar K; Bootla D; Kaur N; Pruthvi CR; Krishnappa D; Santosh K; Guleria V; Rohit MK
Indian Heart J; 2020; 72(2):107-112. PubMed ID: 32534682
[TBL] [Abstract][Full Text] [Related]
14. Multicenter nit-occlud® PDA-R patent. Ductus arteriosus occlusion device trial: initial and six-month results.
Granja MA; Trentacoste L; Rivarola M; Barbosa JD; Lucini V; Peirone A; Spillman A
Catheter Cardiovasc Interv; 2015 Aug; 86(2):258-63. PubMed ID: 23460494
[TBL] [Abstract][Full Text] [Related]
15. The new occlutech duct occluder: immediate results, procedural challenges, and short-term follow-up.
Kudumula V; Taliotis D; Duke C
J Invasive Cardiol; 2015 May; 27(5):250-7. PubMed ID: 25929302
[TBL] [Abstract][Full Text] [Related]
16. Experience with 205 procedures of transcatheter closure of ductus arteriosus in 182 patients, with special reference to residual shunts and long-term follow-up.
Ali Khan MA; al Yousef S; Mullins CE; Sawyer W
J Thorac Cardiovasc Surg; 1992 Dec; 104(6):1721-7. PubMed ID: 1341428
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous device closure of pediatirc patent ductus arteriosus through femoral artery guidance by transthoracic echocardiography without radiation and contrast agents.
Ye Z; Li Z; Yi H; Zhu Y; Sun Y; Li P; Ma N
J Cardiothorac Surg; 2020 May; 15(1):107. PubMed ID: 32448306
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous closure of patent ductus arteriosus in children using amplatzer duct occluder II: relationship between PDA type and risk of device protrusion into the descending aorta.
Masri S; El Rassi I; Arabi M; Tabbakh A; Bitar F
Catheter Cardiovasc Interv; 2015 Aug; 86(2):E66-72. PubMed ID: 26032159
[TBL] [Abstract][Full Text] [Related]
19. Transcatheter closure of hemodynamic significant patent ductus arteriosus in 32 premature infants by amplatzer ductal occluder additional size-ADOIIAS.
Morville P; Akhavi A
Catheter Cardiovasc Interv; 2017 Oct; 90(4):612-617. PubMed ID: 28471089
[TBL] [Abstract][Full Text] [Related]
20. Long-term clinical experience with Amplatzer Ductal Occluder II for closure of the persistent arterial duct in children.
Kang SL; Morgan G; Forsey J; Tometzki A; Martin R
Catheter Cardiovasc Interv; 2014 Jun; 83(7):1102-8. PubMed ID: 24403100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
